Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

U.S. Department of Health and Human Services
Daman Kumari
 

 Contact Info

 
Tel: 301-594-5260
Email: damank@helix.nih.gov
 

 Select Experience

 
  • Staff ScientistNIDDK, NIH2006-present
  • Research FellowNIDDK, NIH2003-2006
  • Visiting FellowNIDDK, NIH1998-2003
  • Project AssistantNational Institute of Immunology1997-1998
  • Ph.D.Jawaharlal Nehru University1997
  • M.S.Maharaja Sayajirao University1990
  • B.S.Maharaja Sayajirao University1988
 

 Related Links

 

Daman Kumari, Ph.D.

Staff Scientist, Office of the Chief, Laboratory of Cell and Molecular Biology
Specialties
  • Chromosome Biology/Epigenetics
  • Molecular Biology/Biochemistry
  • Stem Cells/Induced Pluripotent Stem Cells

​Publications

A selection of recent and significant publications can be viewed below.

Publications
Hayward BE, Zhou Y, Kumari D, Usdin K. A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders. J Mol Diagn. 2016 Aug 8; 18 (2016 Aug 8; 5; 18):762-74. [Full Text/Abstract]
Kumari D, Usdin K. Sustained expression of FMR1 mRNA from reactivated fragile X syndrome alleles after treatment with small molecules that prevent trimethylation of H3K27. Hum Mol Genet. 2016 Jul 4; 25 (25; 2016 Jul 4; 17):3689-3698. [Full Text/Abstract]
Zhao XN, Kumari D, Gupta S, Wu D, Evanitsky M, Yang W, Usdin K. Mutsβ generates both expansions and contractions in a mouse model of the Fragile X-associated disorders. Hum Mol Genet. 2015 Sep 29; 24 (2015 Sep 29; 24):7087-96. [Full Text/Abstract]
Kumari D, Hayward B, Nakamura AJ, Bonner WM, Usdin K. Evidence for chromosome fragility at the frataxin locus in Friedreich ataxia. Mutat Res. 2015 Aug 30; 781 (2015 Aug 30; 781):14-21. [Full Text/Abstract]
Kumari D, Swaroop M, Southall N, Huang W, Zheng W, Usdin K. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells. Stem Cells Transl Med. 2015 May 21; 4 (7; 4; 2015 May 21):800-8. [Full Text/Abstract]
Usdin K, Kumari D. Repeat-mediated epigenetic dysregulation of the FMR1 gene in the fragile X-related disorders. Front Genet. 2015 Jun 3; 6 (6; 2015 Jun 3):192. [Full Text/Abstract]
Kumari D, Bhattacharya A, Nadel J, Moulton K, Zeak NM, Glicksman A, Dobkin C, Brick DJ, Schwartz PH, Smith CB, Klann E, Usdin K. Identification of fragile x syndrome specific molecular markers in human fibroblasts: a useful model to test the efficacy of therapeutic drugs. Hum Mutat. 2014 Sep 16; 35 (35; 2014 Sep 16; 12):1485-94. [Full Text/Abstract]
Kumari D, Usdin K. Polycomb group complexes are recruited to reactivated FMR1 alleles in Fragile X syndrome in response to FMR1 transcription. Hum Mol Genet. 2014 Jul 23; 23 (23; 2014 Jul 23; 24):6575-83. [Full Text/Abstract]
Yudkin D, Hayward BE, Aladjem MI, Kumari D, Usdin K. Chromosome fragility and the abnormal replication of the FMR1 locus in fragile X syndrome. Hum Mol Genet. 2014 Jun 1; 23 (2014 Jun 1; 23; 11):2940-52. [Full Text/Abstract]
Usdin K, Hayward BE, Kumari D, Lokanga RA, Sciascia N, Zhao XN. Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet. 2014 Jul 17; 5 (2014 Jul 17; 5):226. [Full Text/Abstract]
Lokanga RA, Entezam A, Kumari D, Yudkin D, Qin M, Smith CB, Usdin K. Somatic expansion in mouse and human carriers of fragile X premutation alleles. Hum Mutat. 2013 Jan; 34 (34; 1; 2013 Jan):157-66. [Full Text/Abstract]
Kumari D, Lokanga R, Yudkin D, Zhao XN, Usdin K. Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia. Biochim Biophys Acta. 2012 Jul; 1819 (7; 2012 Jul; 1819):802-10. [Full Text/Abstract]
Kumari D, Usdin K. Is Friedreich ataxia an epigenetic disorder?. Clin Epigenetics. 2012 Jan 30; 4 (4; 2012 Jan 30; 1):2. [Full Text/Abstract]
Kumari D, Biacsi RE, Usdin K. Repeat expansion affects both transcription initiation and elongation in friedreich ataxia cells. J Biol Chem. 2011 Feb 11; 286 (6; 2011 Feb 11; 286):4209-15. [Full Text/Abstract]
Kumari D, Usdin K. The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet. 2010 Dec 1; 19 (23; 19; 2010 Dec 1):4634-42. [Full Text/Abstract]
Kumari D, Somma V, Nakamura AJ, Bonner WM, D'Ambrosio E, Usdin K. The role of DNA damage response pathways in chromosome fragility in Fragile X syndrome. Nucleic Acids Res. 2009 Jul; 37 (37; 2009 Jul; 13):4385-92. [Full Text/Abstract]
Kumari D, Usdin K. Chromatin remodeling in the noncoding repeat expansion diseases. J Biol Chem. 2009 Mar 20; 284 (2009 Mar 20; 284; 12):7413-7. [Full Text/Abstract]
Biacsi R, Kumari D, Usdin K. SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet. 2008 Mar 7; 4 (2008 Mar 7; 4; 3):e1000017. [Full Text/Abstract]
Greene E, Mahishi L, Entezam A, Kumari D, Usdin K. Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia. Nucleic Acids Res. 2007; 35 (35; 10; 2007):3383-90. [Full Text/Abstract]
Handa V, Goldwater D, Stiles D, Cam M, Poy G, Kumari D, Usdin K. Long CGG-repeat tracts are toxic to human cells: implications for carriers of Fragile X premutation alleles. FEBS Lett. 2005 May 9; 579 (2005 May 9; 579; 12):2702-8. [Full Text/Abstract]
Kumari D, Gabrielian A, Wheeler D, Usdin K. The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter. Biochem J. 2005 Mar 1; 386 (Pt 2; 2005 Mar 1; 386):297-303. [Full Text/Abstract]
Greene E, Entezam A, Kumari D, Usdin K. Ancient repeated DNA elements and the regulation of the human frataxin promoter. Genomics. 2005 Feb; 85 (85; 2005 Feb; 2):221-30. [Full Text/Abstract]
Kumari D, Mital A, Gupta M, Goyle S. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis. Neurol India. 2003 Jun; 51 (2003 Jun; 2; 51):223-6. [Full Text/Abstract]
Kumari D, Usdin K. Interaction of the transcription factors USF1, USF2, and alpha -Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome. J Biol Chem. 2001 Feb 9; 276 (6; 276; 2001 Feb 9):4357-64. [Full Text/Abstract]
Kumari D, Gupta M, Goyle S. Detection of deletion in the dystrophin gene of a patient with quadriceps myopathy. Neurol India. 2000 Mar; 48 (2000 Mar; 48; 1):68-71. [Full Text/Abstract]
Mital A, Kumari D, Gupta M, Goyle S. Molecular characterisation of Duchenne muscular dystrophy and phenotypic correlation. J Neurol Sci. 1998 May 7; 157 (157; 1998 May 7; 2):179-86. [Full Text/Abstract]